
Jeffrey Jenks
Adjunct Associate Professor in the Department of Medicine · Duke University Hospital
Credentials: · · · · · · ·
History
Research
Review · The Lancet Infectious Diseases · 2021 · 382 citations
The Antifungal Pipeline: Fosmanogepix, Ibrexafungerp, Olorofim, Opelconazole, and Rezafungin
Review · Drugs · 2021 · Last of 12 authors · 359 citations
Review · The Lancet Infectious Diseases · 2025 · 323 citations

16 papers

12 papers
- SR
6 papers

3 papers

3 papers · 2 as a fellow

3 papers
- JB
3 papers
- MM
3 papers
Clinical trials
- 2021
Isavuconazole for the Prevention of COVID-19-associated Pulmonary Aspergillosis
Principal investigator · Terminated · Phase 3
Jeffrey Jenks, MD, MPH







